scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1003474860 |
P356 | DOI | 10.1186/1471-2288-12-180 |
P932 | PMC publication ID | 3533513 |
P698 | PubMed publication ID | 23181419 |
P5875 | ResearchGate publication ID | 233771355 |
P50 | author | Jerry Avorn | Q6183214 |
Sebastian Schneeweiss | Q60162120 | ||
Jeremy Rassen | Q79318138 | ||
Jessica L Myers | Q85653213 | ||
Robert J Glynn | Q88253834 | ||
Daniel H Solomon | Q91503755 | ||
Seoyoung C Kim | Q40305956 | ||
P2093 | author name string | Kenneth J Rothman | |
Jun Liu | |||
Gregory W Daniel | |||
Joseph Singer | |||
P2860 | cites work | 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (updating the 200 | Q50577270 |
Biased estimation of the odds ratio in case-control studies due to the use of ad hoc methods of correcting for missing values for confounding variables. | Q52862354 | ||
Using the outcome for imputation of missing predictor values was preferred. | Q53010230 | ||
ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association task force on | Q59356508 | ||
Intensive versus moderate lipid lowering with statins after acute coronary syndromes | Q29619716 | ||
Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data | Q30664587 | ||
Multiple imputation for missing laboratory data: an example from infectious disease epidemiology | Q33509246 | ||
A basic study design for expedited safety signal evaluation based on electronic healthcare data | Q33648230 | ||
Joint association of hyperuricemia and reduced GFR on cardiovascular morbidity: a historical cohort study based on laboratory and claims data from a national insurance provider | Q33969455 | ||
Challenges and benefits of adding laboratory data to a mortality risk adjustment method | Q34039861 | ||
Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial | Q34550538 | ||
Efficacy of lipid profiles in prediction of coronary disease | Q35773954 | ||
Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records | Q35816364 | ||
Statins in elderly patients with acute coronary syndrome: an analysis of dose and class effects in typical practice | Q36014026 | ||
A review of uses of health care utilization databases for epidemiologic research on therapeutics | Q36111277 | ||
Impact of change in high-density lipoprotein cholesterol from baseline on risk for major cardiovascular events | Q37741076 | ||
A critical look at methods for handling missing covariates in epidemiologic regression analyses | Q40383757 | ||
A propensity score-matched cohort study of the effect of statins, mainly fluvastatin, on the occurrence of acute myocardial infarction | Q44693419 | ||
P275 | copyright license | Creative Commons Attribution 2.0 Generic | Q19125117 |
P6216 | copyright status | copyrighted | Q50423863 |
P304 | page(s) | 180 | |
P577 | publication date | 2012-11-26 | |
P1433 | published in | BMC Medical Research Methodology | Q15752152 |
P1476 | title | Supplementing claims data with outpatient laboratory test results to improve confounding adjustment in effectiveness studies of lipid-lowering treatments | |
P478 | volume | 12 |
Q48060751 | Appropriate baseline laboratory testing following ACEI or ARB initiation by Medicare FFS beneficiaries |
Q38937245 | Cardiovascular Safety of Tocilizumab Versus Tumor Necrosis Factor Inhibitors in Patients With Rheumatoid Arthritis: A Multi-Database Cohort Study |
Q33914132 | Claims-based algorithms for identifying Medicare beneficiaries at high estimated risk for coronary heart disease events: a cross-sectional study |
Q38842063 | Conducting Privacy-Preserving Multivariable Propensity Score Analysis When Patient Covariate Information Is Stored in Separate Locations |
Q41165531 | Development and Validation of the RxDx-Dementia Risk Index to Predict Dementia in Patients with Type 2 Diabetes and Hypertension |
Q36573102 | Disease-modifying antirheumatic drug use and the risk of incident hyperlipidemia in patients with early rheumatoid arthritis: a retrospective cohort study |
Q35642254 | Effects of xanthine oxidase inhibitors on cardiovascular disease in patients with gout: a cohort study |
Q30787929 | Electronic clinical laboratory test results data tables: lessons from Mini-Sentinel |
Q38620987 | Evaluation of Electronic Healthcare Databases for Post-Marketing Drug Safety Surveillance and Pharmacoepidemiology in China |
Q43161044 | Few Disparities in Baseline Laboratory Testing After the Diuretic or Digoxin Initiation by Medicare Fee-For-Service Beneficiaries |
Q39473502 | Gout and the Risk of Non-vertebral Fracture |
Q35666013 | Incorporating linked healthcare claims to improve confounding control in a study of in-hospital medication use. |
Q90106906 | Lab-based and diagnosis-based chronic kidney disease recognition and staging concordance |
Q26865575 | Measuring frailty using claims data for pharmacoepidemiologic studies of mortality in older adults: evidence and recommendations |
Q60301584 | Measuring prevalence and incidence of chronic conditions in claims and electronic health record databases |
Q35136099 | Prevalence and characteristics of patients with low levels of low-density lipoprotein cholesterol in northern Denmark: a descriptive study |
Q98726150 | Propensity score prediction for electronic healthcare databases using Super Learner and High-dimensional Propensity Score Methods |
Q36132510 | Real World Data in Adaptive Biomedical Innovation: A Framework for Generating Evidence Fit for Decision-Making |
Search more.